Skip to content

Construction and promotion of multidisciplinary and stereoscopic diagnosis and treatment mode of endometriosis

Construction and promotion of multidisciplinary and stereoscopic diagnosis and treatment mode of endometriosis

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000036903
Enrollment
Unknown
Registered
2020-08-25
Start date
2020-09-01
Completion date
Unknown
Last updated
2020-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

endometriosis

Interventions

1:Dienogest Tablets
2:oral contraceptive

Sponsors

Obstetrics and Gynecology Hospital of Fudan University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. be initially diagnosed with endometriosis at the Obstetrics and Gynecology Hospital of Fudan University; 2. Aged 15 to 49 years old; 3. The final postoperative diagnosis should be endometriosis and confirmed by histopathological examination; 4. Complete in-patient medical history information, preoperative examination and surgical imaging data; 5. Women should be able to express their complaints and answers to symptoms in well mental and physical state.

Exclusion criteria

Exclusion criteria: 1. refused to follow-up; 2. Have Received endometriosis-related hormone therapy for more than 3 months before surgery; 3. Surgery is not performed by the fixed attending physician; 4. Complete in-patient medical history information, preoperative examination and surgical imaging data; 5. Pathological diagnosis does not support the evidence of endometriosis; 6. Pregnancies or lactation; or patients who are allergic to the experimental drug; or those who have participated in other clinical trials.

Design outcomes

Primary

MeasureTime frame
VAS score;CA125;EMAb;coagulation;Platelet aggregation rate(PAGT);FSH;doppler ultrasound;SF-36/EHP30/EQ-5HD;liver function;renal function;E2;AMH;blood routine examination;recurrence rate;pregnancy rate;

Countries

China

Contacts

Public ContactXiaofang Yi

Obstetrics and Gynecology Hospital of Fudan University

xyi@fudan.edu.cn+86 15026585241

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026